摘要:
The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein A, R 1 , R 2 , R 3 , R 4 , R 5 and n are as defined herein and the use of such compounds for the treatment of disorders or diseases mediated by aldosterone synthase. The invention also relates to pharmaceutical compositions and combinations comprising compounds of formula I.
摘要:
The present invention provides a compound of formula I;
or a pharmaceutically acceptable salt thereof, wherein A, R 1 , R 2 , R 3 , R 4 , R 5 and n are as defined herein and the use of such compounds for the treatment of disorders or diseases mediated by aldosterone synthase. The invention also relates to pharmaceutical compositions and combinations comprising compounds of formula I.
摘要:
A process is provided for preparing a conjugate of Formula (I-A) or (I) comprising a polypeptide containing n number of tyrosine units, where n is an integer greater than or equal to 1, dispersed within the amino acid chain having and amino terminus end (A1) and an acid terminus end (A2) of the protein or polypeptide and having a weight average molecular weight equal to or greater than 10,000 Daltons (10 kDa), wherein the conjugate comprises a number m of tyrosine conjugates (modified tyrosine residues) as depicted in Formula (I-A) or (I), where m is at least one and is less than or equal to n: where X, Lg, L and R are as defined herein.
摘要:
The invention provides methods to prepare protein conjugates from proteins having at least four accessible cysteine residues. In one embodiment, an antibody with four reducible disulfide linkages is reduced to provide four pairs of free cysteines. Each pair of free cysteines is reacted with a 1,3-dihaloacetone or similar reactant, linking the sulfur atoms of each pair together though a 3-carbon tether with a reactive ketone. A pair of these reactive ketones are linked together with and used to attach a single payload molecule, thus conjugating the antibody to two payload groups. This method gives a stabilized antibody conjugate with high selectivity for a ratio of two payloads per antibody.
摘要:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 and n are defined herein. The invention also relates to a method for manufacturing compounds of the invention, and their therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.